CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 37 enrolled
Drug / intervention
Rocuronium and Sugammadexdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02247466
NCT02247466Phase 4Completed
CompareCT.gov

Optimizing Surgical Conditions During Laparoscopic Umbilical, Incisional -and Linea Alba Herniotomy With Deep Neuromuscular Blockade

Herlev Hospital·interventional·Posted Sep 25, 2014·Updated Jul 2, 2019

In Brief

A Phase 4 clinical trial evaluating Rocuronium and Sugammadex for Laparoscopic Herniotomy. Completed, enrolled 37 participants across 2 sites.

Detailed Summary

The purpose of this study is to investigate surgical work space and surgical conditions in patients scheduled for laparoscopic umbilical, -linea alba and incisional herniotomy. The patients will act as their own control with evaluation of surgical work space and surgical conditions during both deep NMB and no NMB.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaparoscopic Herniotomy
CountriesDenmark
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 25, 2014
Enrollment StartFeb 1, 2015
Primary CompletionFeb 23, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.8 years ago

Interventions

Rocuronium and Sugammadexdrug